MT-RNR2 and acute myeloid leukemia: In this context, the aim of this study was to evaluate the HN protein profile of AML patients and compare it with the HN protein profile of healthy donors through proteomic analysis of BM plasma to identify differentially expressed proteins that could be potential biomarkers for AML regardless of the categorization and risk classification of AML.